Clinical Trial Update: Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating boceprevir in previously untreated patients with chronic hepatitis C genotype 1; results on safety and efficacy have been posted foll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Boceprevir (boceprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2011-06-14